biology

Mirko Beljanski

Mirko Beljanski is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Mirko Beljanski rather than just read about it. In short: Mirko Beljanski (27 March 1923 – 27 October 1998) was a French-Serbian molecular biologist who studied bacteria, its resistance to antibiotics and the interaction of RNA and DNA. He performed research at the CNRS and also the Pasteur Institute, discovering reverse transcriptase in bacteria in 1971.

Key takeaways

Mirko Beljanski belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Mirko Beljanski to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Mirko Beljanski from memory before moving on to harder problems.

Reference excerpt

Mirko Beljanski (27 March 1923 – 27 October 1998) was a French-Serbian molecular biologist who studied bacteria, its resistance to antibiotics and the interaction of RNA and DNA. He performed research at the CNRS and also the Pasteur Institute, discovering reverse transcriptase in bacteria in 1971. His later research focused on therapeutic concepts, anticancer and antiviral remedies.

Early life and education Beljanski was born in 1923 in Yugoslavia. His father was an iron worker, his mother a seamstress, and had two older sisters. He attended lyceum in Novi Sad while living with an uncle. After World War II, he received educational offers from the Yugoslavian government to study in either Moscow or Paris. He decided to study in France where he met and married Monique Lucas, daughter of René Lucas and granddaughter of Pauline Ramart. He received a PhD in 1948 from the University of Paris and began working at the Pasteur Institute in Paris as a researcher in molecular biology.

Career While at the Pasteur Institute, Beljanski's early research focused on the study of the origin of bacterial resistance to streptomycin. During this time he studied the interaction of RNA and DNA and the resistance of bacterial strains to antibiotics. He published several articles on how bacteria accumulated RNAs during the acquisition of resistance to different antibiotics. In 1951, the grant Beljanski was working under expired but he was allowed to stay in France to continue his research. He worked at the Institute with Michel Macheboeuf, but left in 1953 upon the death of Macheboeuf. He joined the CNRS where he continued his research. Beljanski returned to the Pasteur Institute in 1959 where he worked alongside his wife Monique and under Jacques Monod, the new head of the Pasteur Institute. In 1971, Beljanski discovered reverse transcriptase in bacteria. This was part of a larger research on DNA and RNA that led him to oppose the central dogma of molecular biology promoted by Monod, head of the Pasteur Institute. After he pursued his work against the advice of the Institute, Beljanski was made to leave in 1978, but still continued to publish scientific papers. He also obtained patents. While at the Faculty of Pharmacy, Beljanski focused his research on radiation protection. Beljanski believed he had found antivirals effective against cancer and AIDS. A product made of flavopereirin, extracted from the Brazilian Pao pereira tree and called PB100 was claimed to be superior to AZT, which Beljanski called "real poison". Another molecule was rauvolfia vomitoria's alstonine. After his mandatory retirement in 1988, Beljanski opened a research center in Isère, focusing on his therapeutic concepts, anticancer and antiviral remedies. His compounds were used in France and other European countries. In 1994, Beljanski was charged with illicit practice of medicine, later being found not guilty of the charges. He was subsequently charged by the French Department of Health for the illicit practice of pharmacy in 1995, but died in 1998 before the case was heard in court. During this time, French President François Mitterrand received treatment for prostate cancer which included the use of Beljanski's products. In 1996, Beljanski's laboratory was seized after the death of Mitterrand. In 2002, the European Court of Human Rights ruled that the length of a second criminal investigation had been excessive and made a financial award to his widow.

Death and legacy Beljanski died from cancer in Paris on 27 October 1998. A namesake foundation was launched for Beljanski in 1999. The Foundation, with a branch in the United States focuses on environmental toxins and is based on the research of Beljanski.

Publications Mirko Beljanski (1983). The Regulation of DNA Replication and Transcription (3 ed.). Demos Medical (2013). ISBN 9781620700198.

Illustrations

Worked examples

Example 1 — a first encounter with Mirko Beljanski

Start with the simplest possible case. Write down what Mirko Beljanski claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Mirko Beljanski before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Mirko Beljanski ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Mirko Beljanski

In research: Mirko Beljanski appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Mirko Beljanski in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Mirko Beljanski is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1923 births, 1998 deaths, Alternative cancer treatment advocates, so understanding it makes those chapters shorter.
In everyday life: Look for Mirko Beljanski outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Mirko Beljanski” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Mirko Beljanski in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Mirko Beljanski means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Mirko Beljanski out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Mirko Beljanski in simple terms?

Why does Mirko Beljanski matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Mirko Beljanski?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Mirko Beljanski.